Levetiracetam (LEV) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

Sunnybrook Health Sciences Centre1

Indications

Prodromal Alzheimer Disease1
Hippocampal Hyperactivation1
Alzheimer's Disease1

Other1 trial

Levetiracetam for Persons at Risk for Alzheimer's Disease

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.